Distinguished in Intestinal Pseudo-Obstruction

Greger Lindberg

Karolinska Institutet
Huddinge, AB, SE 
Distinguished in Intestinal Pseudo-Obstruction
Karolinska Institutet
Huddinge, AB, SE 
OverviewLocationsClinical Research

Overview

Greger Lindberg practices in Huddinge, Sweden. Lindberg is rated as a Distinguished expert by MediFind in the treatment of Intestinal Pseudo-Obstruction. Their top areas of expertise are Irritable Bowel Syndrome (IBS), Intestinal Pseudo-Obstruction, Collagenous Colitis, Diarrhea, and Endoscopy.

Their clinical research consists of co-authoring 53 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Intestinal Pseudo-Obstruction.

Locations

Karolinska Institutet
Huddinge, AB, Sweden
Other Locations
Stockholm, AB, Sweden
Uppsala, C, Sweden
Solna, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
Mesalazine Treatment in IBS, a Double-blind Placebo-controlled Phase II Intervention Study in Adult Patients
Mesalazine Treatment in IBS, a Double-blind Placebo-controlled Phase II Intervention Study in Adult Patients
Enrollment Status: Completed
Publish Date: February 24, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

53 Total Publications

Diagnosis and treatment of bile acid diarrhea
Diagnosis and treatment of bile acid diarrhea
Journal: Lakartidningen
Published: April 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lindberg's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile